Pure Biologics

Pure Biologics Net Margin

The Net Profit Margin of Pure Biologics (PUR.WA) as of Nov 12, 2026 is -37,572.63 %. In the previous year, Net Profit Margin was -3,983.69 % — a change of 843.16% (lower).

Net Margin

-37,572.63 %

YoY

843.16%

Last updated:

Net Profit Margin of Pure Biologics is 2023 -37,572.63 % . Net Profit Margin of Pure Biologics was 2022 -3,983.69 % . It decreases by 843.16% lower compared to the previous year.

Pure Biologics's net margin stands at -37,572.6%, down from -28.1% several years earlier.

The Pure Biologics Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2016
-33.59 PLN
Jan 1, 2017
-42.04 PLN
Jan 1, 2018
-7.23 PLN
Jan 1, 2019
-28.08 PLN
Jan 1, 2020
-2,116.26 PLN
Jan 1, 2021
-5,146.06 PLN
Jan 1, 2022
-3,983.69 PLN
Jan 1, 2023
-37,572.63 PLN
The Pure Biologics Net Margin history
YEARNet MarginYoY
-37,572.63 %+843.16%
-3,983.69 %-22.59%
-5,146.06 %+143.17%
-2,116.26 %+7,435.63%
-28.08 %+288.32%
-7.23 %-82.80%
-42.04 %+25.15%
-33.59 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Pure Biologics Stock analysis

What does Pure Biologics do? Pure Biologics SA, headquartered in Wrocław, Poland, operates in the Health Care sector as a biotechnology company. It focuses on research and development of innovative biological medicines and medical devices for therapeutic and diagnostic applications. The company employs 53 full-time staff and was listed on the stock market on 11 December 2018. Founded in August 2010, it remains based in Wrocław, focusing on biopharmaceutical solutions. Pure Biologics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pure Biologics stock

Net Profit Margin of Pure Biologics is -37,572.63 % in 2023.

Net Profit Margin of Pure Biologics changed from -3,983.69 % to -37,572.63 %, representing a 843.16% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Pure Biologics since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Pure Biologics with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Pure Biologics

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Pure Biologics